• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素通过增加前列腺癌细胞中己糖激酶 2 和 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶 2 的活性来刺激糖酵解以进行从头脂质合成。

Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.

机构信息

Department of Biochemistry and Molecular Biology, Institute of Genetic Science, Center for Chronic Metabolic Disease Research, Brain Korea 21 Project for Medical Science, Yonsei University, College of Medicine, Seodaemungu, Seoul, Korea.

出版信息

Biochem J. 2011 Jan 1;433(1):225-33. doi: 10.1042/BJ20101104.

DOI:10.1042/BJ20101104
PMID:20958264
Abstract

Up-regulation of lipogenesis by androgen is one of the most characteristic metabolic features of LNCaP prostate cancer cells. The present study revealed that androgen increases glucose utilization for de novo lipogenesis in LNCaP cells through the activation of HK2 (hexokinase 2) and activation of the cardiac isoform of PFKFB2 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase). Activation of PKA (cAMP-dependent protein kinase) by androgen increased phosphorylation of CREB [CRE (cAMP-response element)-binding protein], which in turn bound to CRE on the promoter of the HK2 gene resulting in transcriptional activation of the HK2 gene. Up-regulation of PFKFB2 expression was mediated by the direct binding of ligand-activated androgen receptor to the PFKFB2 promoter. The activated PI3K (phosphoinositide 3-kinase)/Akt signalling pathway in LNCaP cells contributes to the phosphorylation of PFKFB2 at Ser466 and Ser483, resulting in the constitutive activation of PFK-2 (6-phosphofructo-2-kinase) activity. Glucose uptake and lipogenesis were severely blocked by knocking-down of PFKFB2 using siRNA (small interfering RNA) or by inhibition of PFK-2 activity with LY294002 treatment. Taken together, our results suggest that the induction of de novo lipid synthesis by androgen requires the transcriptional up-regulation of HK2 and PFKFB2, and phosphorylation of PFKFB2 generated by the PI3K/Akt signalling pathway to supply the source for lipogenesis from glucose in prostate cancer cells.

摘要

雄激素上调脂肪生成是 LNCaP 前列腺癌细胞最具特征性的代谢特征之一。本研究揭示,雄激素通过激活 HK2(己糖激酶 2)和激活 PFKFB2 的心脏同工型(6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶),增加 LNCaP 细胞从头脂肪生成的葡萄糖利用。雄激素激活的 PKA(cAMP 依赖性蛋白激酶)增加了 CREB(cAMP 反应元件结合蛋白)的磷酸化,后者反过来与 HK2 基因启动子上的 CRE 结合,导致 HK2 基因的转录激活。PFKFB2 表达的上调是通过配体激活的雄激素受体与 PFKFB2 启动子的直接结合介导的。LNCaP 细胞中激活的 PI3K(磷酸肌醇 3-激酶)/Akt 信号通路有助于 PFKFB2 在 Ser466 和 Ser483 处的磷酸化,导致 PFK-2(6-磷酸果糖-2-激酶)活性的组成型激活。用 siRNA(小干扰 RNA)敲低 PFKFB2 或用 LY294002 抑制 PFK-2 活性严重阻断了葡萄糖摄取和脂肪生成。总之,我们的结果表明,雄激素诱导的从头脂质合成需要 HK2 和 PFKFB2 的转录上调,以及由 PI3K/Akt 信号通路产生的 PFKFB2 磷酸化,为前列腺癌细胞中葡萄糖来源的脂肪生成提供来源。

相似文献

1
Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.雄激素通过增加前列腺癌细胞中己糖激酶 2 和 6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶 2 的活性来刺激糖酵解以进行从头脂质合成。
Biochem J. 2011 Jan 1;433(1):225-33. doi: 10.1042/BJ20101104.
2
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.雄激素受体非基因组信号的变化与LNCaP细胞向雄激素非依赖性的转变相关。
Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121.
3
Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.雄激素可刺激人前列腺癌细胞系LNCaP中的脂肪酸合酶。
Cancer Res. 1997 Mar 15;57(6):1086-90.
4
Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.血管活性肠肽通过蛋白激酶A依赖性细胞外信号调节激酶途径在前列腺癌LNCaP细胞中反式激活雄激素受体。
Mol Pharmacol. 2007 Jul;72(1):73-85. doi: 10.1124/mol.107.033894. Epub 2007 Apr 12.
5
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.雄激素通过雷帕霉素哺乳动物靶点激活和细胞周期蛋白D蛋白的转录后增加来诱导前列腺癌细胞增殖。
Cancer Res. 2006 Aug 1;66(15):7783-92. doi: 10.1158/0008-5472.CAN-05-4472.
6
Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells.雄激素依赖性激活前列腺癌细胞中人巨细胞病毒主要立即早期启动子。
Prostate. 2008 Sep 15;68(13):1450-60. doi: 10.1002/pros.20817.
7
Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.雄激素通过激活前列腺癌细胞中的视网膜母细胞瘤(RB)蛋白来抑制Bcl-2表达。
Oncogene. 2004 Mar 18;23(12):2161-76. doi: 10.1038/sj.onc.1207326.
8
Regulation of FGF8 expression by the androgen receptor in human prostate cancer.雄激素受体对人前列腺癌中FGF8表达的调控
Oncogene. 2002 Aug 1;21(33):5069-80. doi: 10.1038/sj.onc.1205663.
9
Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.核因子κB p50/p65、Fra-1和JunD的组成性激活对于前列腺癌中白细胞介素6表达失调至关重要。
Cancer Res. 2003 May 1;63(9):2206-15.
10
Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.G蛋白信号调节因子2(RGS2)抑制前列腺癌细胞中雄激素受体的非雄激素依赖性激活。
Oncogene. 2006 Jun 22;25(26):3719-34. doi: 10.1038/sj.onc.1209408. Epub 2006 Jan 30.

引用本文的文献

1
Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer.由CAMKK2-CREB信号传导调节的胆固醇代谢促进去势抵抗性前列腺癌。
Cell Rep. 2025 Jun 24;44(6):115792. doi: 10.1016/j.celrep.2025.115792. Epub 2025 Jun 7.
2
Bibliometric analysis of glycolysis and prostate cancer research from 2004 to 2024.2004年至2024年糖酵解与前列腺癌研究的文献计量分析
Discov Oncol. 2025 Jan 12;16(1):34. doi: 10.1007/s12672-025-01790-2.
3
Assessments of prostate cancer cell functions highlight differences between a pan-PI3K/mTOR inhibitor, gedatolisib, and single-node inhibitors of the PI3K/AKT/mTOR pathway.
对前列腺癌细胞功能的评估突出了泛PI3K/mTOR抑制剂gedatolisib与PI3K/AKT/mTOR途径单节点抑制剂之间的差异。
Mol Oncol. 2025 Jan;19(1):225-247. doi: 10.1002/1878-0261.13703. Epub 2024 Aug 2.
4
Placenta-Specific Transcripts Containing Androgen Response Elements Are Altered In Silico by Male Growth Outcomes.雄激素反应元件的胎盘特异性转录本在计算机上因男性生长结果而改变。
Int J Mol Sci. 2024 Jan 30;25(3):1688. doi: 10.3390/ijms25031688.
5
Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1.找到关键所在:磷酸果糖激酶-1如何在空间和时间上协调葡萄糖代谢
Cancers (Basel). 2023 Dec 19;16(1):16. doi: 10.3390/cancers16010016.
6
Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer.油酸通过PTEN/AKT/mTOR信号通路对子宫内膜癌发挥抗增殖和抗侵袭作用。
Cancers (Basel). 2023 Nov 14;15(22):5407. doi: 10.3390/cancers15225407.
7
Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma.磷酸果糖激酶-2/果糖-2,6-二磷酸酶(PFKFB)家族成员在口腔鳞状细胞癌中的比较临床意义及生物学作用
Cancer Cell Int. 2023 Nov 2;23(1):257. doi: 10.1186/s12935-023-03110-6.
8
Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer.Cav1在前列腺癌中的分子发病机制、作用机制及治疗
Discov Oncol. 2023 Nov 1;14(1):196. doi: 10.1007/s12672-023-00813-0.
9
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.肿瘤代谢——用于癌症免疫治疗的改写型纳米药物
ACS Cent Sci. 2023 Sep 22;9(10):1864-1893. doi: 10.1021/acscentsci.3c00702. eCollection 2023 Oct 25.
10
Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases.解析神经退行性和肿瘤性疾病的交叉发病机制之谜。
Int J Mol Sci. 2023 Sep 29;24(19):14766. doi: 10.3390/ijms241914766.